What does CUSIP 74587V107 represent in this 13F holders report?

CUSIP 74587V107 is the security identifier for PBYI - PUMA BIOTECHNOLOGY, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held PBYI - PUMA BIOTECHNOLOGY, INC. - Common Stock in Q1 2016?

114 institutional investors reported PBYI - PUMA BIOTECHNOLOGY, INC. - Common Stock for Q1 2016. Use the holders table for investor-level position and value details.

PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI)

CUSIP: 74587V107

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class: Equity / Common Stock
Shares outstanding: 49,633,071
Total 13F shares: 30,412,423
Share change: -1,797,037
Total reported value: $892,904,817
Put/Call ratio: 58%
Price per share: $29.37
Number of holders: 114
Value change: -$134,999,214
Number of buys: 62
Number of sells: 64

Quarterly Holders Quick Answers

What is CUSIP 74587V107?
CUSIP 74587V107 identifies PBYI - PUMA BIOTECHNOLOGY, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2016
Previous quarter: Q4 2015

Recent filing periods for CUSIP 74587V107:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of PBYI - PUMA BIOTECHNOLOGY, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	11%	5,686,668	$445,835,000	—	31 Dec 2015	13F
FMR LLC	13F	Company	9.8%	4,865,362	$381,444,000	—	31 Dec 2015	13F
Grantham, Mayo, Van Otterloo & Co. LLC	13F	Company	5.8%	2,899,776	$227,342,000	—	31 Dec 2015	13F
ORBIMED ADVISORS LLC	13F	Company	4.5%	2,238,825	$175,524,000	—	31 Dec 2015	13F
Capital Research Global Investors	13F	Company	3.7%	1,826,600	$143,205,000	—	31 Dec 2015	13F
VANGUARD GROUP INC	13F	Company	3.6%	1,789,112	$140,265,000	—	31 Dec 2015	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	3.5%	1,719,612	$134,818,000	—	31 Dec 2015	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	2.4%	1,201,171	$94,172,000	—	31 Dec 2015	13F
Point72 Asset Management, L.P.	13F	Company	1.9%	945,478	$74,125,000	—	31 Dec 2015	13F
STATE STREET CORP	13F	Company	1.5%	761,829	$59,731,000	—	31 Dec 2015	13F
JANUS HENDERSON INVESTORS US LLC	13F	Company	1.2%	587,302	$46,044,000	—	31 Dec 2015	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	1.2%	570,847	$44,754,000	—	31 Dec 2015	13F
CORNERSTONE CAPITAL MANAGEMENT LLC	13F	Company	0.96%	477,005	$37,397,000	—	31 Dec 2015	13F
BB BIOTECH AG	13F	Company	0.87%	431,991	$33,868,000	—	31 Dec 2015	13F
FRANKLIN RESOURCES INC	13F	Company	0.59%	294,444	$23,084,000	—	31 Dec 2015	13F
CITADEL ADVISORS LLC	13F	Company	0.57%	284,427	$22,299,000	—	31 Dec 2015	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.56%	276,211	$21,655,000	—	31 Dec 2015	13F
COLUMBUS CIRCLE INVESTORS	13F	Company	0.55%	272,517	$21,365,000	—	31 Dec 2015	13F
CAPITAL GUARDIAN TRUST CO	13F	Company	0.55%	271,850	$21,313,000	—	31 Dec 2015	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.53%	263,286	$20,642,000	—	31 Dec 2015	13F
Tekla Capital Management LLC	13F	Company	0.52%	260,200	$20,400,000	—	31 Dec 2015	13F
BlackRock Fund Advisors	13F	Company	0.49%	242,424	$19,006,000	—	31 Dec 2015	13F
DEUTSCHE BANK AG\	13F	Company	0.48%	239,788	$18,798,000	—	31 Dec 2015	13F
Lamond Capital Partners LLC	13F	Company	0.44%	220,780	$17,309,000	—	31 Dec 2015	13F
RUSSELL FRANK CO/	13F	Company	0.43%	214,746	$16,434,000	—	31 Dec 2015	13F
NORGES BANK	13F	Company	0.42%	206,876	$16,219,000	—	31 Dec 2015	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.41%	202,570	$15,881,000	—	31 Dec 2015	13F
D. E. Shaw & Co., Inc.	13F	Company	0.34%	170,670	$13,381,000	—	31 Dec 2015	13F
WEATHERBIE CAPITAL, LLC	13F	Company	0.32%	158,475	$12,424,000	—	31 Dec 2015	13F
CAPITAL INTERNATIONAL LTD /CA/	13F	Company	0.28%	139,897	$10,968,000	—	31 Dec 2015	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.26%	127,162	$9,969,000	—	31 Dec 2015	13F
Capital International Sarl	13F	Company	0.22%	108,005	$8,468,000	—	31 Dec 2015	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.21%	105,804	$8,295,000	—	31 Dec 2015	13F
Bank of New York Mellon Corp	13F	Company	0.21%	102,862	$8,063,000	—	31 Dec 2015	13F
UBS Group AG	13F	Company	0.2%	99,858	$7,829,000	—	31 Dec 2015	13F
MARSHALL WACE, LLP	13F	Company	0.19%	94,965	$7,445,000	—	31 Dec 2015	13F
NORTHERN TRUST CORP	13F	Company	0.18%	91,719	$7,190,000	—	31 Dec 2015	13F
Capital International, Inc./CA/	13F	Company	0.17%	85,450	$6,699,000	—	31 Dec 2015	13F
S.c.a. Candriam	13F	Individual	0.17%	84,300	$6,609,000	—	31 Dec 2015	13F
Asset Management One Co., Ltd.	13F	Company	0.16%	79,388	$6,247,000	—	31 Dec 2015	13F
HIGHBRIDGE CAPITAL MANAGEMENT LLC	13F	Company	0.15%	73,899	$5,794,000	—	31 Dec 2015	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.15%	73,199	$5,739,000	—	31 Dec 2015	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.15%	73,142	$5,713,000	—	31 Dec 2015	13F
TEACHERS ADVISORS, LLC	13F	Company	0.14%	67,860	$5,320,000	—	31 Dec 2015	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.13%	63,042	$4,943,000	—	31 Dec 2015	13F
JPMORGAN CHASE & CO	13F	Company	0.13%	62,102	$4,869,000	—	31 Dec 2015	13F
CREDIT SUISSE AG/	13F	Company	0.12%	60,307	$4,729,000	—	31 Dec 2015	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.12%	57,300	$4,492,000	—	31 Dec 2015	13F
GUGGENHEIM CAPITAL LLC	13F	Company	0.11%	53,715	$4,211,000	—	31 Dec 2015	13F
TD ASSET MANAGEMENT INC	13F	Company	0.1%	48,100	$3,771,000	—	31 Dec 2015	13F

Institutional Holders of PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) as of Q1 2016

As of 31 Mar 2016, PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) was held by 114 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 30,412,423 shares. The largest 10 holders included ADAGE CAPITAL PARTNERS GP, L.L.C., FMR LLC, ORBIMED ADVISORS LLC, Grantham, Mayo, Van Otterloo & Co. LLC, JANUS CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, Point72 Asset Management, L.P., STATE STREET CORP, and MILLENNIUM MANAGEMENT LLC. This page lists 114 institutional shareholders reporting positions in this security for the Q1 2016 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2016 vs Q4 2015 Across Filers

Q4 2015 holders

131

Q1 2016 holders

114

Holder diff

-17

Investor	Q4 2015 Shares	Q1 2016 Shares	Share Diff	Share Chg %	Q4 2015 Value $	Q1 2016 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.